Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Inhibition of cardiac hERG potassium channels by tetracyclic antidepressant mianserin.
Scherer D, von Löwenstern K, Zitron E, Scholz EP, Bloehs R, Kathöfer S, Thomas D, Bauer A, Katus HA, Karle CA, Kiesecker C.
???displayArticle.abstract???
The antidepressant mianserin exhibits a tetracyclic structure that is different from typical tricyclic antidepressants (TCA) and that of selective serotonin reuptake inhibitors. In comparison to the older TCA, mianserin has been shown to have a superior risk profile regarding proarrhythmic effects, both in vitro and in vivo. However, the underlying molecular electrophysiological basis has not been elucidated to date. Therefore, we studied the effects of mianserin on cardiac hERG potassium channels, the predominant target of drug-induced proarrhythmia. HERG channels were expressed in the Xenopus oocyte expression system and in human embryonic kidney (HEK) cells and currents were measured with two-microelectrode voltage-clamp and whole-cell patch-clamp, respectively. Mianserin inhibited hERG currents in a dose-dependent manner with an IC(50) of 3.2 micromol/l in HEK cells. Onset of blockade was slow and the inhibitory effect was not reversible upon wash-out of the drug. In hERG channel mutants, Y652A and F656A, lacking aromatic residues in the S6 domain, the effect of mianserin was significantly reduced in comparison to the wild type. Mianserin inhibited hERG currents in the open and inactivated state, but not in the closed states. HERG inactivation kinetics were significantly altered by mianserin without marked effects on channel activation kinetics. The inhibitory effect was not frequency dependent. In conclusion, mianserin is a low-affinity hERG-blocking agent. However, taken together with the lack of APD-prolongation shown in other studies, mianserin seems to have a good safety profile. Lack of consistent QT prolonging effects of mianserin in previous studies may therefore be linked to additional effects such as inhibition of other cardiac ion channels. However, as demonstrated by clinical case reports, mianserin can induce proarrhythmic effects in susceptible patients. Therefore, in patients with complex co-medication (i.e., additional hERG-blocking agents) and in patients with risk factors for acquired long QT syndrome as well as in cases of overdose, adequate monitoring should be recommended.
Burgess,
Cardiovascular responses to mianserin hydrochloride: a comparison with tricyclic antidepressant drugs.
1978, Pubmed
Burgess,
Cardiovascular responses to mianserin hydrochloride: a comparison with tricyclic antidepressant drugs.
1978,
Pubmed Casis,
Mechanism of block of cardiac transient outward K+ current (I(to)) by antidepressant drugs.
1998,
Pubmed Casis,
Imipramine, mianserine and maprotiline block delayed rectifier potassium current in ventricular myocytes.
2002,
Pubmed Cohen,
Should the use of selective serotonin reuptake inhibitors in child and adolescent depression be banned?
2007,
Pubmed Dam,
Morning fluoxetine plus evening mianserin versus morning fluoxetine plus evening placebo in the acute treatment of major depression.
1998,
Pubmed Duan,
Verapamil blocks HERG channel by the helix residue Y652 and F656 in the S6 transmembrane domain.
2007,
Pubmed
,
Xenbase Duncan,
Inhibition of the HERG potassium channel by the tricyclic antidepressant doxepin.
2007,
Pubmed Ferreri,
Benefits from mianserin augmentation of fluoxetine in patients with major depression non-responders to fluoxetine alone.
2001,
Pubmed Glassman,
Risks of antidepressants in the elderly: tricyclic antidepressants and arrhythmia-revising risks.
1994,
Pubmed Haine,
Mianserin and ventricular tachycardia: case report and review of the literature.
2006,
Pubmed Hidalgo Urbano,
[Enlargement of QT-interval in a patient with coronary disease treated with mianserin].
2003,
Pubmed Hondeghem,
Blinded test in isolated female rabbit heart reliably identifies action potential duration prolongation and proarrhythmic drugs: importance of triangulation, reverse use dependence, and instability.
2003,
Pubmed Jo,
Blockade of the HERG human cardiac K(+) channel by the antidepressant drug amitriptyline.
2000,
Pubmed
,
Xenbase Kannankeril,
Genetic susceptibility to acquired long QT syndrome: pharmacologic challenge in first-degree relatives.
2005,
Pubmed Karle,
Human cardiac inwardly-rectifying K+ channel Kir(2.1b) is inhibited by direct protein kinase C-dependent regulation in human isolated cardiomyocytes and in an expression system.
2002,
Pubmed
,
Xenbase Khan,
Treatment of severe depressive illness: a double-blind comparison of mianserin and long-acting amitriptyline.
1982,
Pubmed Kiehn,
Pathways of HERG inactivation.
1999,
Pubmed
,
Xenbase Kiehn,
Inhibitory effects of the class III antiarrhythmic drug amiodarone on cloned HERG potassium channels.
1999,
Pubmed
,
Xenbase Kiesecker,
Class Ia anti-arrhythmic drug ajmaline blocks HERG potassium channels: mode of action.
2004,
Pubmed
,
Xenbase Kiesecker,
Atypical tetracyclic antidepressant maprotiline is an antagonist at cardiac hERG potassium channels.
2006,
Pubmed
,
Xenbase Kim,
Inhibitory effects of coronary vasodilator papaverine on heterologously-expressed HERG currents in Xenopus oocytes.
2007,
Pubmed
,
Xenbase Kinugawa,
Electrophysiological studies on the effects of mianserin, a tetracyclic antidepressant agent, on isolated guinea-pig papillary muscle.
1988,
Pubmed Lavoie,
Atypical antidepressants inhibit depolarization-induced calcium uptake in rat hippocampus synaptosomes.
1997,
Pubmed Madeja,
Follicular tissues reduce drug effects on ion channels in oocytes of Xenopus laevis.
1997,
Pubmed
,
Xenbase Maguire,
The pharmacokinetics of mianserin in elderly depressed patients.
1983,
Pubmed Mitcheson,
A structural basis for drug-induced long QT syndrome.
2000,
Pubmed
,
Xenbase Moreno,
Effects of irbesartan on cloned potassium channels involved in human cardiac repolarization.
2003,
Pubmed Nishimoto,
Comparative effects of the antidepressants amitriptyline, mianserin and adinazolam on hemodynamics and ECG in myocardial infarcted dogs.
1989,
Pubmed Park,
Blockade of HERG K+ channel by an antihistamine drug brompheniramine requires the channel binding within the S6 residue Y652 and F656.
2008,
Pubmed Redfern,
Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development.
2003,
Pubmed Roden,
Genetics of acquired long QT syndrome.
2005,
Pubmed Roden,
Long QT syndrome: reduced repolarization reserve and the genetic link.
2006,
Pubmed Scholz,
Drug binding to aromatic residues in the HERG channel pore cavity as possible explanation for acquired Long QT syndrome by antiparkinsonian drug budipine.
2003,
Pubmed
,
Xenbase Thomas,
High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872.
2001,
Pubmed
,
Xenbase Thomas,
The antidepressant drug fluoxetine is an inhibitor of human ether-a-go-go-related gene (HERG) potassium channels.
2002,
Pubmed
,
Xenbase Tsujimae,
Frequency-dependent effects of various IKr blockers on cardiac action potential duration in a human atrial model.
2007,
Pubmed Witchel,
Troubleshooting problems with in vitro screening of drugs for QT interval prolongation using HERG K+ channels expressed in mammalian cell lines and Xenopus oocytes.
2002,
Pubmed
,
Xenbase Zitron,
Inhibition of cardiac HERG potassium channels by the atypical antidepressant trazodone.
2004,
Pubmed
,
Xenbase
